Cognition Therapeutics, Inc. (CGTX)
0.9796
-0.01
(-1.05%)
USD |
NASDAQ |
Sep 10, 16:00
0.95
-0.03
(-3.02%)
After-Hours: 20:00
Cognition Therapeutics Debt to Equity Ratio : 0.0178 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0178 |
| March 31, 2026 | 0.0155 |
| December 31, 2025 | 0.0186 |
| September 30, 2025 | 0.0104 |
| June 30, 2025 | 0.0666 |
| March 31, 2025 | 0.0386 |
| December 31, 2024 | 0.0285 |
| September 30, 2024 | 0.04 |
| June 30, 2024 | 0.0271 |
| March 31, 2024 | 0.0231 |
| December 31, 2023 | 0.0071 |
| Date | Value |
|---|---|
| September 30, 2023 | 0.0254 |
| June 30, 2023 | 0.0225 |
| March 31, 2023 | 0.0226 |
| December 31, 2022 | 0.0456 |
| September 30, 2022 | 0.0182 |
| June 30, 2022 | 0.0129 |
| March 31, 2022 | 0.0122 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.9774 |
| June 30, 2021 | -1.013 |
| March 31, 2021 | -1.003 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Zevra Therapeutics, Inc. | 0.0069 |
| Bristol Myers Squibb Co. | 2.019 |
| Structure Therapeutics, Inc. | 0.0046 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 38.90M |
| Total Liabilities (Quarterly) | 5.872M |
| Shareholders Equity (Quarterly) | 33.02M |
| Current Ratio | 7.027 |
| Net Debt Paydown Yield | -0.02% |